Only adaptive business will survive in 2021, and there will be fewer offices – Shymkiv

Only adaptive business will survive in 2021, and there will be fewer offices – Shymkiv Dmytro Shymkiv: Remote work reduces the demand for office premises, but it raises the demands to housing
Photo: Darnitsa press-office

Business has to adapt, find other forms of cooperation with clients, use innovations, digital technologies because of the coronavirus pandemic, said the chairman of the Board of Darnitsa Group Dmytro Shymkiv.

The transition of business to online, remote work and the increasingly active use of digital tools in all spheres of life – the trends of 2020 will have a logical continuation in 2021. This has been stated on the air of radio NV by the chairman of the Board of Darnitsa Group Dmytro Shymkiv.

According to him, the coronavirus pandemic and lockdown restrictions in certain segments have reduced the revenues of Ukrainian businesses up to 80%.

“Only adaptive companies will survive. Business has to adapt, find other forms of cooperation with clients, use innovations, digital technologies,” said Shymkiv.

He reminded that the Covid crisis this year has accelerated the implementation of solutions that had only been discussed before. According to the forecast, digital platforms, instant messengers and chats, and delivery services will continue to gain momentum in 2021. At the same time, the lockdown continuation will be a hard trial for builders, developers and owners of office premises.

“Remote work reduces the demand for office premises, but it raises the demands to housing. We will want a separate room or a comfortable workplace, as well as space for doing sports. In addition, there are many people who want to stay out of town. Accordingly, the de-urbanization trend will intensify,” added Dmytro Shymkiv.

Darnitsa Pharmaceutical company was founded in 1930. It has been the leader in Ukraine in terms of the volume of drugs production since 1998. The strategic development directions are cardiology, neurology and pain management. The beneficiaries of the company are the Zagoriy family.

Pharmaceutical company Darnitsa was founded in 1930. There are about 280 medicines and substances in company’s portfolio.  The Zagoriy Family are the ultimate beneficiaries of Darnitsa. The company increased its net profit by 30% in 2019.